to study the clinical course of a new coronavirus infection in the provision of specialized medical care to children in a hospital and post-mortem follow-up. Results: All patients had laboratory-confirmed infection with SARS-CoV-2 (the result of real-time PCR, specific for SARS-CoV-2, was positive). The patients were divided into severe patients, including 2 (4.6%) patients with severe cases on admission and 32 (74.4%) patients with moderate cases, hospitalization in the intensive care unit was not, the remaining cases 9 (21% ) the disease was mild. All sick children of COVID-19 were discharged with recovery. In the observed children of the course of COVID-19, an increase in body temperature was noted 88%, vomiting 58%, diarrhea 68%, cough 77%, shortness of breath 7%. Every fifth patient has pneumonia as the only symptom of the disease. In this case, in order to establish a diagnosis and timely prescribe therapy, it is necessary to conduct an X-ray examination of the chest cavity organs. In children, mild and moderate forms of the disease are predominantly found, and the possibility of radiological verification of pneumonia in a patient with good health is also revealed. Another striking characteristic of COVID-19 is that it affects several vital organs (for example, the lungs, the digestive tract and the nervous system), as evidenced by the clinical course of the disease.


COVID-19 children clinical manifestations


How to Cite
Хudoydodova S.G. (2023). Clinical Aspects of the Catamnesis of Children Covid-19. Texas Journal of Medical Science, 26, 18–20. Retrieved from https://zienjournals.com/index.php/tjms/article/view/4615


  1. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19. Pediatr Infect Dis J. 2020; March 12, Volume Online First – Issue. DOI: 10.1097/INF.0000000000002660
  2. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Published May 15. - 2020. https://www.who.int/publicationsdetail
  3. Мелехина Е.В. и др. Клинические особенности течения COVID-19 у детей различных возрастных групп. Вопросы практической педиатрии. 2020.(2). С. 7-20.
  4. Туйчиев Л.Н., Худайкулова Г.К., Рахматуллаева Ш.Б. Муминова М.Т., Эралиев У.Э., Мирхошимов М.Б. Частота инфекции COVID-19 у детей. «Актуальные проблемы морфологии в связи с пандемией COVID-19» Материалы Международной научно-практической конференции. 2021, С.110.
  5. Худойдодова С.Г., Фармонова М.В. 2021. Covid-19 у детей. Central Asian Journal of Medical and Natural Science. (Oct. 2021), 183-186. DOI:https://doi.org/10.47494/cajmns.vi0.374.
  6. Облокулов А.Р., Хусенова З.З., Эргашов М.М. Значение уровня прокальцитонина при назначении и мониторнинга антибактериальной терапии пациентов с COVID-19 // Журнал гепато-гастроэнтерологических исследований. 2021. Том -1. С. 115-117.
  7. Xudoydodova S.G., Farmanova M.A. Clinical manifestations of Covid-19 in children // Новый день в медицине. 2020. №2(34/3). C. 355-358.
  8. A.A. Elmurodova. 2022. Specific Features of the Hemostatic System in Covid-19. Central Asian Journal of Medical and Natural Science. 3, 2 (Mar. 2022), 82-85.
  9. Худойдодова С.Г. Респираторные проявление COVID-19 у детей. // Тиббиётда янги кун. 2022 №2 (40). С. 176-179.
  10. Худойдодова С.Г., Фарманова М.А. COVID-19 и дети. // Инфекция, иммунитет и фармакология 2021. №3 С.180-184.